Associated Papers
KIT-related piebaldism in a Chinese girl.
Zhu L et al.
American Journal of Medical Genetics. Part A, 2020
Novel mutations of KIT gene in two Korean patients: variegated shades of phenotypes in tyrosine kinase 1 domain.
Lee H et al.
Journal of Dermatological Science, 2014
Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL et al.
Journal of Cutaneous Pathology, 2013
The energy landscape analysis of cancer mutations in protein kinases.
Dixit A et al.
Plos One, 2011
21998754 (PubMed )
Supplement: pone.0026071.s009.doc
Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets.
Isokpehi RD et al.
Bioinformatics and Biology Insights, 2010
20981267 (PubMed )
Supplement: BBI-4-supplementary.xls › SNPs3D_-_Substitutions_to_Cys
Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach.
Rajasekaran R et al.
Amino Acids, 2010
Allelic heterogeneity at the equine KIT locus in dominant white (W) horses.
Haase B et al.
Plos Genetics, 2007
17997609 (PubMed )
Supplement: pgen.0030195.sg002.pdf
Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A et al.
British Journal of Haematology, 2007
Identification of a novel point mutation of mouse proto-oncogene c-kit through N-ethyl-N-nitrosourea mutagenesis.
Ruan HB et al.
Genetics, 2005
Three novel mutations of the proto-oncogene KIT cause human piebaldism.
Syrris P et al.
American Journal of Medical Genetics, 2000
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I.
Orlova KV et al.
Case Reports in Oncology, 0
31043947 (PubMed )
Supplement: cro-0012-0109-s01.pdf
Select a paper to view details